ARK Genomic Revolution ETF
ARKG
4 hedge funds and large institutions have $897K invested in ARK Genomic Revolution ETF in 2016 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
367% more capital inflows, than outflows
Capital inflows: $103K | Capital outflows: $22K
33% less funds holding
Funds holding: 6 → 4 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$103K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$16K |
| 2 |
IFP Advisors
Tampa,
Florida
|
-$6K |
ARKG Hedge Fund Activity: Q2 2016 in Review
4 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q2 2016, worth a combined $897K — up 5% from $854K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ARKG and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Jane Street, adding an estimated $103K. The largest seller was UBS Group, exiting entirely with an estimated $16K sold.
- 4 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q2 2016, down from 6 in Q1 2016.
- Funds reported $897K of ARK Genomic Revolution ETF stock for Q2 2016, up 5% quarter-over-quarter.
- 0 funds opened new ARK Genomic Revolution ETF positions in Q2 2016 and 2 closed out, a net change of -2 holders.
- The largest ARK Genomic Revolution ETF buyer in Q2 2016 was Jane Street, an estimated $103K added.
- The largest ARK Genomic Revolution ETF seller in Q2 2016 was UBS Group, an estimated $16K sold.
Based on aggregated 13F filings for Q2 2016.